A 15-min premedication for 1-h paclitaxel infusion: optimizing patients' care

Lung Cancer. 2007 Nov;58(2):300-1. doi: 10.1016/j.lungcan.2007.08.009. Epub 2007 Sep 18.

Abstract

Background: Paclitaxel is a plant product highly active in numerous cancers, but anaphylactic-like hypersensitivity reactions with it have been reported in about 28% of patients receiving the drug. Thirty to sixty minutes are needed to give a standard premedication with steroids and diphenhydramine, leading to patients and nurses' discomfort and stealing time from other infusional treatments.

Patients and methods: Eighty-nine patients with advanced NSCLC never pre-treated with taxanes, received paclitaxel followed by gemcitabine on days 1, 8, 15 q4wks. Premedication consisted of prednisone 25 mg/os on day 0 and hydrocortisone plus clorfenamina maleato given intravenous on day 1 by a 15 min infusion immediately before paclitaxel administration.

Results: Hypersensitivity reactions occurred in 3/341 (0.8%) cycles. In all three cases we observed severe dyspnoea and bronchospasm, that required treatment discontinuation but one was probably due to gemcitabine and another had a protracting time after premedication.

Conclusions: A 15-min premedication infusion administered immediately before paclitaxel appeared to be highly effective in patients treated with 1h-infusion paclitaxel.

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Aged
  • Drug Administration Schedule
  • Humans
  • Infusions, Intravenous
  • Middle Aged
  • Paclitaxel / administration & dosage*
  • Paclitaxel / therapeutic use*
  • Patient Care*
  • Premedication*
  • Time Factors

Substances

  • Paclitaxel